These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10382992)

  • 1. Diuretics in congestive heart failure: new evidence for old problems.
    Haller C
    Nephrol Dial Transplant; 1999 Jun; 14(6):1358-60. PubMed ID: 10382992
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diuretic therapy in congestive heart failure--new views on spironolactone therapy].
    Haller C
    Ther Umsch; 2000 Jun; 57(6):374-9. PubMed ID: 10894022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial hypertension.
    Dyckner T; Wester PO; Widman L
    Eur J Clin Pharmacol; 1986; 30(5):535-40. PubMed ID: 3758141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical amd metabolic results of a particular combination thiazide-antialdosterone in heart failure].
    Miraglia G; Nava A; Dalla Volta S
    Clin Ter; 1974 Mar; 68(5):445-51. PubMed ID: 4599565
    [No Abstract]   [Full Text] [Related]  

  • 5. Spironolactone in the management of congestive heart failure.
    Muller JE
    Am J Cardiol; 1990 Jun; 65(23):51K-53K. PubMed ID: 2353671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The problem of potassium and diuretics].
    Bernik V
    Rev Paul Med; 1972 Sep; 80(3):127-32. PubMed ID: 4602416
    [No Abstract]   [Full Text] [Related]  

  • 7. Spironolactone and congestive heart-failure.
    Georges B; Beguin C; Jadoul M
    Lancet; 2000 Apr; 355(9212):1369-70. PubMed ID: 10776778
    [No Abstract]   [Full Text] [Related]  

  • 8. [Indication, selection, dosage and pro's and con's for use of diuretics in chronic congestive heart failure].
    Saimyoji H; Ohara Y; Kubo S
    Nihon Rinsho; 1970 Apr; 28(4):1250-7. PubMed ID: 4913895
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New aspects of the use of spironolactone and its association with thiabutazide (per os and in injections) in the treatment of grave cardiac insufficiency].
    Căruntu M; Mihail A
    Med Interna (Bucur); 1974 Feb; 26(2):177-88. PubMed ID: 4828933
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperaldosteronism and the use of aldactone in cardiac insufficiency].
    Korochkin IM; Matveeva IV; Sidorenko BA; Arshakuni RO
    Kardiologiia; 1968 Dec; 8(12):74-81. PubMed ID: 5736746
    [No Abstract]   [Full Text] [Related]  

  • 12. Ask the doctor. I am a 50-year-old man with congestive heart failure. My doctor has me on all the usual drugs, and a couple of years ago added spironolactone. I did okay with it for a while, but then began to notice that my breasts were getting bigger and began to hurt. My doctor agreed that I should stop taking spironolactone, but I wonder if I am missing out on something.
    Lee TH
    Harv Heart Lett; 2003 Oct; 14(2):8. PubMed ID: 14576040
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term mechanisms of sudden cardiac death in congestive heart failure.
    Helfant RH
    Am J Cardiol; 1990 Jun; 65(23):41K-43K. PubMed ID: 2353668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutically induced aldosteronism in hydropic cardiac insufficiency].
    Kaufmann W
    Arzneimittelforschung; 1969 May; 19(5):802-3. PubMed ID: 5819794
    [No Abstract]   [Full Text] [Related]  

  • 16. [Myocardial hyperexcitability in decompensated cardiopathies. Effect of spironolactone].
    Tourniaire A; Blum J; Guyot R; Madignier M
    Sem Hop; 1969 Apr; 45(20):1388-92. PubMed ID: 4182541
    [No Abstract]   [Full Text] [Related]  

  • 17. Diuretics.
    Havard CW
    Practitioner; 1974 Oct; 213(1276 SPEC NO):454-66. PubMed ID: 4457838
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aldactazine in the treatment of congestive cardiac insufficiency].
    Koaté P; Diouf S; Coulibaly D; Diop G; Kébé MB; Dia B; Ba E; Sanogho S; Seck G
    Bull Soc Med Afr Noire Lang Fr; 1977; 22(4):365-76. PubMed ID: 612384
    [No Abstract]   [Full Text] [Related]  

  • 19. Diuretics in the treatment of patients who present congestive heart failure and hypertension.
    Reyes AJ
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S104-13. PubMed ID: 11986906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What's old is new again. Spironolactone and heart failure.
    Lock M; Chun R
    Can Fam Physician; 1999 Nov; 45():2621-2. PubMed ID: 10587769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.